Medikine, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Medikine, Inc. is a biotechnology research company based in Menlo Park, California. It focuses on discovering therapeutics for oncology, autoimmune disorders, and infectious diseases by using a disruptive platform that generates modular PEPTIKINES, which are smaller and structurally distinct from the natural cytokines they imitate. These agents can be further optimized for pharmacokinetic properties or additional pharmacologic features, with the lead candidate, MDK-703, planned to enter clinical trials, as an Fc-fusion protein containing an IL-7 PEPTIKINE to support T cell responses while avoiding neutralizing antibodies to native IL-7. The company is advancing its pipeline and seeking partnerships to broaden clinical-stage opportunities, leveraging a team experienced in drug discovery and immuno-oncology. A recent development noted is Medikine’s presentation of preliminary Phase 1 results for MDK-703 at SITC 2022.